Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRICE T ROWE GROUP INCTROW · Entity 3212 | Director | March 30, 2022 | March 31, 2022 |
| Synchrony FinancialSYF · Entity 3184 | Director | May 12, 2022 | May 16, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRICE T ROWE GROUP INC
Report date March 30, 2022 · Filed March 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,790.3976 |
Reported balance
After 2022-03-30 transaction · row 1
1 source rowRow 1 · 2022-03-30 · Grant · Acquired 104.9156 · Balance 22,790.3976 F1: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. |
Filing footnotes · ownership attribution and instrument terms
F1: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests.
Synchrony Financial
Report date May 12, 2022 · Filed May 16, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent UnitSEC Table I · non-derivative | Direct | 31,402 |
Reported balance
After 2022-05-12 transaction · row 1
1 source rowRow 1 · 2022-05-12 · Grant · Acquired 24 · Balance 31,402 F1: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent units accrued on May 12, 2022 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-11-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-11-26 · Gift · Disposed 120 · Balance 1,300 Row 2 · 2018-11-28 · Disposition to issuer · Disposed 1,300 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 990 · Balance 0 F2: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
| Deferred Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 2,772.0058 · Balance 0 F3: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Previously reported Restricted Stock Units granted under the Non-Employee Director Compensation Plan (the "Plan") on May 18, 2018. These Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
F3: Deferred Restricted Stock Units accrued under the Plan pursuant to the deferral of Restricted Stock Unit grants. These Deferred Restricted Stock Units were canceled pursuant to the terms of the Plan in exchange for an amount in cash for each Deferred Restricted Stock Unit equal to the closing price of Aetna Common Stock on the closing date under the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2018 Filed Nov 19, 2018 16:56 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 94 | $26.51 | $2,491.94 |
DisclosureSEC source: 0001601712-18-000279 · wf-form4_154266458288027.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,967 F1 · shares: Represents 4, 8, 9, 8, 8, 8, 9, 9, 7, 8, 8 and 9 dividend equivalent units accrued on November 15, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017, December 31, 2017, March 31, 2017, June 31, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 16:09 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,086 | $31.08 | $33,752.88 |
DisclosureSEC source: 0001601712-18-000259 · wf-form4_153851094699717.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,873 F1 · date: Represents restricted stock units that will vest in full on September 30, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. F1 · shares: Represents restricted stock units that will vest in full on September 30, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 17:04 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 47.713 | $109.18 | $5,209.31 |
DisclosureSEC source: 0001127602-18-028679 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,789.632 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 16:37 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 74 | $30.43 | $2,251.82 |
DisclosureSEC source: 0001601712-18-000223 · wf-form4_153479745894052.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,787 F1 · shares: Represents 3, 7, 7, 7, 7, 7, 8, 8, 6, 7, 7 dividend equivalent units accrued on August 16, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017, December 31, 2017, March 31, 2018 and June 30, 2018, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 16:24 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,012 | $33.38 | $33,780.56 |
DisclosureSEC source: 0001601712-18-000195 · wf-form4_153064947445376.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,713 F1 · shares: Represents restricted stock units that will vest in full on June 30, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 13:41 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 44.604 | $116.09 | $5,178.08 |
DisclosureSEC source: 0001127602-18-022412 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,741.919 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| May 18, 2018 Filed May 22, 2018 16:09 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 990 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000100 · edgar.xml · derivative · entry 2 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Underlying: Common Stock · 990 shares Expires not disclosed F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F1 · price: Units convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be deferred to stock unit account. F2 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 18, 2018, November 18, 2018, February 18, 2019, and May 18, 2019, with payment of the Units deferred until May 20, 2019. Upon payment date, Units will be deferred to stock unit account. Read SEC document |
| May 17, 2018 Filed May 21, 2018 16:07 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit | 41 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001601712-18-000176 · wf-form4_152693323179890.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,701 F1 · shares: Represents 2, 4, 5, 4, 4, 4, 5, 5, 4 and 4 dividend equivalent units accrued on May 17, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017, December 31, 2017 and March 31, 2018, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents 2, 4, 5, 4, 4, 4, 5, 5, 4 and 4 dividend equivalent units accrued on May 17, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017, December 31, 2017 and March 31, 2018, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F2 · balance_after: The total reported in Column 5 bas been adjusted to include 170 dividend equivalent units that were previously reported on Table II. Read SEC document |
| April 27, 2018 Filed Apr 30, 2018 20:43 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 1,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015584 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,697.315 F1 · shares: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Stock Unit shares were issued at $114.02 per share, the closing price of TROW shares on April 27, 2018. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 17:21 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,007 | $33.53 | $33,764.71 |
DisclosureSEC source: 0001601712-18-000135 · wf-form4_152279046680997.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,490 F1 · shares: Represents restricted stock units that will vest in full on March 31, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 18:15 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 36.345 | $107.97 | $3,924.17 |
DisclosureSEC source: 0001127602-18-013211 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,942.315 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 19:55 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit · Derivative | 35 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001601712-18-000096 · wf-form4_151882889085585.xml · derivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165 Underlying: Common Stock · 35 shares Expires not disclosed F1 · derivative.exercise_price: Represents 2, 4, 4, 4, 4, 4, 5, 5 and 3 dividend equivalent units accrued on February 15, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · price: Represents 2, 4, 4, 4, 4, 4, 5, 5 and 3 dividend equivalent units accrued on February 15, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · derivative.exercise_date: Represents 2, 4, 4, 4, 4, 4, 5, 5 and 3 dividend equivalent units accrued on February 15, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · derivative.expiration_date: Represents 2, 4, 4, 4, 4, 4, 5, 5 and 3 dividend equivalent units accrued on February 15, 2018 as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 16:36 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 875 | $38.61 | $33,783.75 |
DisclosureSEC source: 0001601712-18-000011 · wf-form4_151501536993073.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,483 F1 · shares: Represents restricted stock units that will vest in full on December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 31, 2017 Filed Feb 14, 2018 16:56 UTC | Synchrony Financial SYF · Entity 3184 | GrantDividend Equivalent Unit · Derivative | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001601712-18-000048 · wf-form5_151864459385584.xml · derivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 Underlying: Common Stock · 130 shares Expires not disclosed F1 · security: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · derivative.exercise_price: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · date: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · shares: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · derivative.exercise_date: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. F1 · derivative.expiration_date: Represents 11, 25, 29, 21, 16, 14, 10 and 4 dividend equivalent units accrued as dividends were paid on the common shares underlying restricted stock units originally granted to the reporting person on December 31, 2015, March 31, 2016, June 30, 2016, September 30, 2016, December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, respectively. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock. Read SEC document |
| December 28, 2017 Filed Dec 29, 2017 21:01 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 30.171 | $105.34 | $3,178.21 |
DisclosureSEC source: 0001127602-17-035628 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,905.97 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 16:08 UTC | Synchrony Financial SYF · Entity 3184 | PurchaseCommon Stock | 3,000 | $33.40 | $100,200.00 |
DisclosureSEC source: 0001601712-17-000164 · wf-form4_151129847729560.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,608 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 17:08 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,087 | $31.05 | $33,751.35 |
DisclosureSEC source: 0001601712-17-000135 · wf-form4_150706488199232.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,608 F1 · shares: Represents restricted stock units that will vest in full on September 30, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 17:43 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 35.041 | $90.13 | $3,158.25 |
DisclosureSEC source: 0001127602-17-028487 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,875.799 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:04 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 1,132 | $29.82 | $33,756.24 |
DisclosureSEC source: 0001601712-17-000075 · wf-form4_149928502510506.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,521 F1 · shares: Represents restricted stock units that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:25 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 42.336 | $74.03 | $3,134.13 |
DisclosureSEC source: 0001127602-17-022486 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,840.758 F1 · shares: This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared by the issuer on it's Common Stock. A portion of these shares were credited as fully-vested dividend reinvestment shares and a portion will be accrued and vest when the corresponding grant vests. Read SEC document |
| May 19, 2017 Filed May 23, 2017 16:34 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 1,203 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-17-000061 · edgar.xml · derivative · entry 2 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,203 Underlying: Common Stock · 1,203 shares Expires not disclosed F1 · derivative.exercise_price: Units convert to Common Stock on a one-for-one basis. F1 · price: Units convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be deferred to stock unit account. F2 · derivative.expiration_date: Restricted Stock Units ("Units") granted under the Aetna Inc. 2010 Non-Employee Director Compensation Plan (the "Plan"). Subject to terms of the Plan, Units will vest in four substantially equal installments on August 19, 2017; November 19, 2017; February 19, 2018, and May 19, 2018, with payment of the Units deferred until May 21, 2018. Upon payment date, Units will be deferred to stock unit account. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 17:43 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 2,837 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015828 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,798.422 F1 · shares: Pursuant to the 2017 Non-Employee Director Equity Plan, this restricted Stock Unit shares were issued at $70.52 per share, the closing price of TROW shares on April 27, 2017. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) the day immediately prior to the Annual Meeting that occurs in the next calendar year following the year in which the Award Shares were granted as reflected on the Notice, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 16:19 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 984 | $34.30 | $33,751.20 |
DisclosureSEC source: 0001601712-17-000050 · wf-form4_149133713966620.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,389 Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 15:29 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 22.056 | $68.21 | $1,504.44 |
DisclosureSEC source: 0001127602-17-013359 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,961.422 F1 · shares: Credited as fully-vested dividend equivalents pursuant to the T. Rowe Price Group Inc. 2007 Non-Employee Director Equity Plan with respect to dividend declared by the issuer on it's Common Stock. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 16:26 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 931 | $36.27 | $33,767.37 |
DisclosureSEC source: 0001601712-17-000016 · wf-form4_148356514748957.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,405 F1 · shares: Represents restricted stock units that will vest in full on December 31, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 15:55 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 18.734 | $75.54 | $1,415.17 |
DisclosureSEC source: 0001127602-17-000012 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,939.366 F1 · shares: Credited as fully-vested dividend equivalents pursuant to the T. Rowe Price Group Inc. 2007 Non-Employee Director Equity Plan with respect to dividend declared by the issuer on it's Common Stock. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 14:12 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-065953 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,920.632 F1 · shares: Pursuant to the Amended and Restated 2007 Non-Employee Director Equity Plan, this Restricted Stock Unit Award was issued at $63.82 per share, the closing price of TROW shares on November 1, 2016. The forfeiture provisions of the this award will lapse upon the earliest of the following: (a) one year after the date of award, (b) the day immediately prior to the annual meeting of stockholders of the Company at which members of the Board of Directors are to be elected that occurs in the next calendar year following the year in which the date of award occurs, (c) death or (d) immediately before and contingent upon the occurrence of a Change in Control. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:10 UTC | Synchrony Financial SYF · Entity 3184 | GrantCommon Stock | 983 | $28.00 | $27,524.00 |
DisclosureSEC source: 0001601712-16-000168 · wf-form4_147561183806325.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,474 F1 · shares: Represents restricted stock units that will vest in full on September 30, 2019. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 18:14 UTC | PRICE T ROWE GROUP INC TROW · Entity 3212 | GrantCommon Stock | 10.792 | $65.54 | $707.31 |
DisclosureSEC source: 0001127602-16-063517 · form4.xml · nonDerivative · entry 1 SNOWE OLYMPIA J. · CIK 0001579077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620.632 F1 · shares: Credited as fully-vested dividend equivalents pursuant to the T. Rowe Price Group Inc. 2007 Non-Employee Director Equity Plan with respect to dividend declared by the issuer on it's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.